| Study |
Reference |
|
Anderka, 2012
|
Anderka M Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol 2012;94:22-30
|
|
Ashkenazi-Hoffnung, 2013
|
Ashkenazi-Hoffnung L Evaluation of the efficacy and safety of bi-daily combination therapy with pyridoxine and doxylamine for nausea and vomiting of pregnancy. Isr Med Assoc J 2013;15:23-6
|
|
Asker, 2005
|
Asker C Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol 2005;61:899-906
|
|
Bérard, 2019
|
Bérard New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy. J Clin Epidemiol 2019; 116:39-48
|
|
Berkovitch, 2002
|
Berkovitch M Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. Am J Perinatol 2002;19:311-6
|
|
Bsat, 2003
|
Bsat FA Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy. J Perinatol 2003;23:531-5
|
|
Bylsma-Howell, 1983
|
Bylsma-Howell M Placental transport of metoclopramide: assessment of maternal and neonatal effects. Can Anaesth Soc J 1983;30:487-92
|
|
Fejzo, 2013
|
Fejzo Antihistamines and other prognostic factors for adverse outcome in hyperemesis gravidarum. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 170:71-6
|
|
Fejzo, 2015
|
Fejzo MS Neurodevelopmental delay in children exposed in utero to hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 2015;189:79-84
|
|
Howard, 1973
|
Howard FA Effect of metoclopramide on gastric emptying during labour. Br Med J 1973;1:446-8 Howard FA The effect of intra-muscular metoclopramide on gastric emptying during labour. Postgrad Med J 1973;49 Suppl 4:suppl 4:53-7
|
|
Huybrechts, 2018
|
Huybrechts KF Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring. JAMA 2018;320:2429-2437
|
|
Kafle, 1993
|
Kafle SK Intrathecal meperidine for elective caesarean section: a comparison with lidocaine. Can J Anaesth 1993;40:718-21
|
|
Lind, 2013
|
Lind Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007. Pharmacoepidemiol Drug Saf 2013; 22:783-93
|
|
Lussos, 1992
|
Lussos SA The antiemetic efficacy and safety of prophylactic metoclopramide for elective cesarean delivery during spinal anesthesia. Reg Anesth 1992;17:126-30
|
|
Matok, 2009
|
Matok I The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med 2009;360:2528-35
|
|
McGarry (Control exposed to perphenazine), 1971
|
McGarry JM A double-blind comparison of the anti-emetic effect during labour of metoclopramide and perphenazine. Br J Anaesth 1971;43:613-5
|
|
McGarry (Unexposed control), 1971
|
McGarry JM A double-blind comparison of the anti-emetic effect during labour of metoclopramide and perphenazine. Br J Anaesth 1971;43:613-5
|
|
Neri, 2005
|
Neri I Acupuncture versus pharmacological approach to reduce Hyperemesis gravidarum discomfort. Minerva Ginecol 2005;57:471-5
|
|
Orr, 1993
|
Orr DA Effects of omeprazole, with and without metoclopramide, in elective obstetric anaesthesia. Anaesthesia 1993;48:114-9
|
|
Pasternak, 2013
|
Pasternak B Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA 2013;310:1601-11
|
|
Shahriari, 2009
|
Shahriari A Prevention of nausea and vomiting in caesarean section under spinal anaesthesia with midazolam or metoclopramide? J Pak Med Assoc 2009;59:756-9
|
|
Sorensen, 2000
|
Sorensen HT Birth outcome following maternal use of metoclopramide. The Euromap study group. Br J Clin Pharmacol 2000;49:264-8
|
|
Zarante, 2009
|
Zarante Impact and risk factors of craniofacial malformations in a Colombian population. Int. J. Pediatr. Otorhinolaryngol. 2009; 73:1434-7
|
